Quoin Pharmaceuticals, Ltd. (QNRX) (CIK 0001671502) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001104659-25-117689
- Form
- CORRESP
- Filer
- Quoin Pharmaceuticals, Ltd. (QNRX) (CIK 0001671502)
- CIK
- 0001671502
- Ticker
- QNRX
- Filed
- 2025-12-02
- SIC industry
- 2834
- HQ
- Kfar Saba
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1671502/000110465925117689/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗